Akebia Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference

CAMBRIDGE, Mass., March 2, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer of Akebia, will participate in a fireside chat at the H.C. Wainwright Global Life Sciences Conference, which takes place virtually March 9-10, 2021. 

The recorded presentation will be available on the Investors section of the Company's website at https://ir.akebia.com beginning Tuesday, March 9.

About Akebia TherapeuticsAkebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics ContactKristen K. Sheppard, Esq.ir@akebia.com 

View original content to download multimedia:http://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-hc-wainwright-global-life-sciences-conference-301237797.html

SOURCE Akebia Therapeutics